Skip to content
PIL Logo

Testosterone Enantate Ampoules

Last Updated on eMC 23-May-2017 View document  | Alliance Pharmaceuticals Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23-May-2017 and displayed until Current

Reasons for adding or updating:

  • Change to section 6 - manufacturer

Updated on 01-Dec-2016 and displayed until 23-May-2017

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions

Updated on 14-Jan-2016 and displayed until 01-Dec-2016

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - use in children/adolescents
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 5 - how to store

Updated on 04-Mar-2015 and displayed until 14-Jan-2016

Reasons for adding or updating:

  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect

Updated on 26-Feb-2014 and displayed until 04-Mar-2015

Reasons for adding or updating:

  • Change to section 1 - what the product is
  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - use in children/adolescents
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - excipient warnings
  • Change to section 3 - dose and frequency
  • Change to section 4 - possible side effects
  • Change to section 5 - how to store
  • Change to section 6 - what the product looks like and pack contents

Updated on 26-Feb-2013 and displayed until 26-Feb-2014

Reasons for adding or updating:

  • Change to section 6 - manufacturer

Updated on 12-Jan-2012 and displayed until 26-Feb-2013

Reasons for adding or updating:

  • Change due to user-testing of patient information

Updated on 01-Feb-2011 and displayed until 12-Jan-2012

Reasons for adding or updating:

  • Change to Marketing Authorisation Holder

Updated on 09-Feb-2007 and displayed until 01-Feb-2011

Reasons for adding or updating:

  • Change of trade or generic name

Updated on 27-Nov-2001 and displayed until 09-Feb-2007

Reasons for adding or updating:

  • New PIL for new product

Updated on 06-Jul-2001 and displayed until 27-Nov-2001

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Company contact details

Alliance Pharmaceuticals

Company image
Address

Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB

Fax

+44 (0)1249 466 977

Telephone

+44 (0)1249 466 966

Medical Information e-mail

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

testosterone enantate

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue